Stravix
MedicalSupply Extremities & Limb Restoration
General payments
$2,634,166
Research payments
$217,242
Through program year 2024, $2,634,166 in general payments and $217,242 in research payments were reported against Stravix (Extremities & Limb Restoration).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $800,434 | 5,151 |
| 2024 | Research | $2,600 | 1 |
| 2023 | General | $610,153 | 5,752 |
| 2023 | Research | $76,473 | 2 |
| 2022 | General | $710,372 | 6,612 |
| 2022 | Research | $96,101 | 5 |
| 2021 | General | $513,207 | 7,251 |
| 2021 | Research | $42,069 | 2 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 89 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 53 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
24,766 general · 10 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.